Gene Symbol | Gene ID | Gene Info |
---|---|---|
GLIS2
|
ENSG00000126603.4 | GLIS family zinc finger 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr16_4364763_4364914 | GLIS2 | 76 | 0.959877 | 0.80 | 9.9e-03 | Click! |
chr16_4356276_4356451 | GLIS2 | 8399 | 0.139740 | 0.79 | 1.2e-02 | Click! |
chr16_4356517_4356801 | GLIS2 | 8103 | 0.140335 | 0.75 | 2.1e-02 | Click! |
chr16_4356859_4357086 | GLIS2 | 7790 | 0.141021 | 0.72 | 3.0e-02 | Click! |
chr16_4366412_4367009 | GLIS2 | 1948 | 0.243845 | 0.66 | 5.2e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_10252991_10253357 | 7.07 |
EIF3G |
eukaryotic translation initiation factor 3, subunit G |
22596 |
0.07 |
chr7_2739159_2739434 | 1.67 |
AMZ1 |
archaelysin family metallopeptidase 1 |
11460 |
0.21 |
chr1_204430993_204431895 | 1.66 |
PIK3C2B |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta |
5030 |
0.21 |
chr10_133973135_133973286 | 1.61 |
RP11-140A10.3 |
|
25293 |
0.18 |
chr17_80259593_80259778 | 1.45 |
CD7 |
CD7 molecule |
15743 |
0.1 |
chr10_133975181_133975332 | 1.41 |
RP11-140A10.3 |
|
23247 |
0.18 |
chr15_75091800_75092051 | 1.35 |
CSK |
c-src tyrosine kinase |
1670 |
0.24 |
chr10_133973365_133973516 | 1.33 |
RP11-140A10.3 |
|
25063 |
0.18 |
chr10_43789226_43789587 | 1.25 |
RASGEF1A |
RasGEF domain family, member 1A |
27039 |
0.17 |
chr17_47824865_47825302 | 1.24 |
FAM117A |
family with sequence similarity 117, member A |
16410 |
0.14 |
chr11_86749150_86749602 | 1.21 |
TMEM135 |
transmembrane protein 135 |
294 |
0.94 |
chrX_48570630_48571127 | 1.21 |
ENSG00000206723 |
. |
12088 |
0.11 |
chr2_70666868_70667067 | 1.20 |
ENSG00000215996 |
. |
15789 |
0.15 |
chr1_25308637_25308788 | 1.20 |
RUNX3 |
runt-related transcription factor 3 |
17211 |
0.18 |
chr10_103593566_103593717 | 1.20 |
KCNIP2 |
Kv channel interacting protein 2 |
3446 |
0.19 |
chr9_139859162_139859313 | 1.18 |
C9orf141 |
chromosome 9 open reading frame 141 |
4458 |
0.07 |
chr1_42271688_42271993 | 1.17 |
ENSG00000264896 |
. |
47028 |
0.18 |
chr20_55975594_55975873 | 1.17 |
RP4-800J21.3 |
|
7615 |
0.16 |
chr1_151799797_151800044 | 1.17 |
RORC |
RAR-related orphan receptor C |
1353 |
0.22 |
chr2_145273950_145274280 | 1.16 |
ZEB2 |
zinc finger E-box binding homeobox 2 |
1000 |
0.52 |
chr9_100693908_100694117 | 1.16 |
C9orf156 |
chromosome 9 open reading frame 156 |
9160 |
0.15 |
chr19_41195953_41196246 | 1.16 |
NUMBL |
numb homolog (Drosophila)-like |
30 |
0.96 |
chr12_31270687_31270867 | 1.13 |
RP11-551L14.1 |
|
1763 |
0.35 |
chr19_30159940_30160094 | 1.13 |
PLEKHF1 |
pleckstrin homology domain containing, family F (with FYVE domain) member 1 |
2236 |
0.36 |
chr17_80260059_80260261 | 1.12 |
CD7 |
CD7 molecule |
15268 |
0.1 |
chr11_67185457_67185617 | 1.12 |
CARNS1 |
carnosine synthase 1 |
1980 |
0.12 |
chr4_78774210_78774388 | 1.11 |
MRPL1 |
mitochondrial ribosomal protein L1 |
9375 |
0.26 |
chr19_42818040_42818392 | 1.10 |
TMEM145 |
transmembrane protein 145 |
687 |
0.5 |
chr5_156644932_156645196 | 1.09 |
CTB-4E7.1 |
|
6326 |
0.14 |
chr17_29820821_29821086 | 1.08 |
RAB11FIP4 |
RAB11 family interacting protein 4 (class II) |
5827 |
0.15 |
chr2_43402102_43402312 | 1.07 |
ZFP36L2 |
ZFP36 ring finger protein-like 2 |
51541 |
0.14 |
chr17_41476671_41476919 | 1.07 |
ARL4D |
ADP-ribosylation factor-like 4D |
468 |
0.69 |
chr1_160611400_160611728 | 1.07 |
SLAMF1 |
signaling lymphocytic activation molecule family member 1 |
5247 |
0.18 |
chr4_919824_920024 | 1.05 |
GAK |
cyclin G associated kinase |
6162 |
0.15 |
chr5_39204147_39204382 | 1.05 |
FYB |
FYN binding protein |
1135 |
0.63 |
chr2_96811667_96811891 | 1.05 |
DUSP2 |
dual specificity phosphatase 2 |
600 |
0.68 |
chr10_6113767_6113953 | 1.04 |
IL2RA |
interleukin 2 receptor, alpha |
9572 |
0.15 |
chr10_133973940_133974091 | 1.04 |
RP11-140A10.3 |
|
24488 |
0.18 |
chr2_233943754_233943945 | 1.04 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
18660 |
0.18 |
chr6_489632_490047 | 1.02 |
RP1-20B11.2 |
|
34332 |
0.22 |
chr11_46367187_46367549 | 1.02 |
DGKZ |
diacylglycerol kinase, zeta |
381 |
0.82 |
chr3_50642105_50642285 | 1.02 |
CISH |
cytokine inducible SH2-containing protein |
7008 |
0.15 |
chr14_98643821_98644049 | 1.02 |
ENSG00000222066 |
. |
154152 |
0.04 |
chr3_71408104_71408255 | 1.02 |
FOXP1 |
forkhead box P1 |
54268 |
0.15 |
chr15_44852872_44853058 | 1.00 |
RP11-151N17.1 |
|
2938 |
0.2 |
chr14_99703175_99703515 | 1.00 |
AL109767.1 |
|
25940 |
0.19 |
chr16_12181748_12181899 | 1.00 |
RP11-276H1.3 |
|
2336 |
0.26 |
chr16_29675395_29675762 | 0.99 |
QPRT |
quinolinate phosphoribosyltransferase |
978 |
0.33 |
chr10_11203608_11204588 | 0.99 |
CELF2 |
CUGBP, Elav-like family member 2 |
2895 |
0.29 |
chr5_66483406_66483586 | 0.99 |
CD180 |
CD180 molecule |
9131 |
0.28 |
chr1_111178112_111178418 | 0.98 |
KCNA2 |
potassium voltage-gated channel, shaker-related subfamily, member 2 |
4169 |
0.21 |
chr2_43421750_43421929 | 0.98 |
ZFP36L2 |
ZFP36 ring finger protein-like 2 |
31909 |
0.19 |
chr19_3360665_3360877 | 0.98 |
NFIC |
nuclear factor I/C (CCAAT-binding transcription factor) |
1090 |
0.51 |
chr1_27970739_27970904 | 0.97 |
FGR |
feline Gardner-Rasheed sarcoma viral oncogene homolog |
9033 |
0.12 |
chr5_177543276_177543552 | 0.97 |
N4BP3 |
NEDD4 binding protein 3 |
2970 |
0.23 |
chr9_98772679_98772830 | 0.97 |
ERCC6L2 |
excision repair cross-complementing rodent repair deficiency, complementation group 6-like 2 |
37635 |
0.18 |
chr21_46331787_46332010 | 0.96 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
523 |
0.65 |
chr11_12378207_12378574 | 0.96 |
ENSG00000264283 |
. |
12076 |
0.19 |
chrX_48378545_48379226 | 0.96 |
EBP |
emopamil binding protein (sterol isomerase) |
661 |
0.53 |
chr8_134073642_134074126 | 0.96 |
SLA |
Src-like-adaptor |
1281 |
0.55 |
chr2_85091739_85091919 | 0.95 |
TRABD2A |
TraB domain containing 2A |
16377 |
0.19 |
chr5_133468083_133468234 | 0.95 |
TCF7 |
transcription factor 7 (T-cell specific, HMG-box) |
8849 |
0.21 |
chr18_60825707_60826108 | 0.95 |
RP11-299P2.1 |
|
7354 |
0.25 |
chr7_99222505_99222744 | 0.94 |
ZSCAN25 |
zinc finger and SCAN domain containing 25 |
5394 |
0.16 |
chr1_25311224_25311505 | 0.94 |
RUNX3 |
runt-related transcription factor 3 |
19863 |
0.18 |
chr1_101576233_101576454 | 0.94 |
ENSG00000252765 |
. |
22366 |
0.17 |
chr19_43032810_43033477 | 0.93 |
CEACAM1 |
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
482 |
0.79 |
chr8_26307373_26307658 | 0.93 |
RP11-14I17.3 |
|
9508 |
0.2 |
chr22_36800480_36800817 | 0.92 |
MYH9 |
myosin, heavy chain 9, non-muscle |
16585 |
0.16 |
chr1_167610101_167610252 | 0.92 |
RP3-455J7.4 |
|
10265 |
0.2 |
chr2_204810952_204811163 | 0.92 |
ICOS |
inducible T-cell co-stimulator |
9554 |
0.28 |
chr19_2561097_2561248 | 0.92 |
CTC-265F19.2 |
|
50688 |
0.09 |
chr16_88545192_88545343 | 0.92 |
ENSG00000263456 |
. |
9941 |
0.17 |
chr22_17701465_17701764 | 0.92 |
CECR1 |
cat eye syndrome chromosome region, candidate 1 |
1124 |
0.53 |
chr14_99449668_99449965 | 0.92 |
AL162151.4 |
|
174937 |
0.03 |
chr22_45704561_45704784 | 0.91 |
FAM118A |
family with sequence similarity 118, member A |
191 |
0.95 |
chr7_8166947_8167257 | 0.91 |
AC006042.6 |
|
13447 |
0.21 |
chr17_55677929_55678185 | 0.91 |
RP11-118E18.4 |
|
7716 |
0.21 |
chr9_116638915_116639161 | 0.91 |
ZNF618 |
zinc finger protein 618 |
408 |
0.9 |
chr17_76248087_76248344 | 0.91 |
TMEM235 |
transmembrane protein 235 |
20093 |
0.13 |
chr7_50195357_50195508 | 0.90 |
AC020743.2 |
|
13013 |
0.23 |
chr1_222593719_222593897 | 0.90 |
ENSG00000222399 |
. |
83269 |
0.09 |
chr17_62982407_62982595 | 0.90 |
AMZ2P1 |
archaelysin family metallopeptidase 2 pseudogene 1 |
12866 |
0.15 |
chr2_69791563_69791714 | 0.90 |
ENSG00000207016 |
. |
44332 |
0.13 |
chr11_95333050_95333201 | 0.90 |
ENSG00000201204 |
. |
126587 |
0.06 |
chr9_95711156_95711443 | 0.90 |
FGD3 |
FYVE, RhoGEF and PH domain containing 3 |
1566 |
0.43 |
chr1_931738_931994 | 0.90 |
HES4 |
hes family bHLH transcription factor 4 |
3495 |
0.11 |
chr1_154389484_154389635 | 0.89 |
RP11-350G8.5 |
|
10519 |
0.13 |
chr12_46655846_46656071 | 0.89 |
SLC38A1 |
solute carrier family 38, member 1 |
5526 |
0.32 |
chr8_145806767_145806918 | 0.89 |
CTD-2517M22.9 |
|
2582 |
0.15 |
chr11_73689201_73689425 | 0.89 |
UCP2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
127 |
0.95 |
chr15_92400702_92400931 | 0.89 |
SLCO3A1 |
solute carrier organic anion transporter family, member 3A1 |
3465 |
0.32 |
chr10_73835799_73836159 | 0.89 |
SPOCK2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
12107 |
0.23 |
chr11_1873282_1874046 | 0.89 |
LSP1 |
lymphocyte-specific protein 1 |
536 |
0.61 |
chr12_6571504_6572054 | 0.89 |
VAMP1 |
vesicle-associated membrane protein 1 (synaptobrevin 1) |
8032 |
0.09 |
chr1_175157741_175158025 | 0.89 |
KIAA0040 |
KIAA0040 |
4007 |
0.31 |
chr16_57168390_57168643 | 0.89 |
CPNE2 |
copine II |
15405 |
0.14 |
chr11_114050972_114051405 | 0.89 |
NNMT |
nicotinamide N-methyltransferase |
77365 |
0.09 |
chr18_77252064_77252215 | 0.88 |
AC018445.1 |
Uncharacterized protein |
23918 |
0.23 |
chrX_153577349_153577500 | 0.88 |
FLNA |
filamin A, alpha |
4113 |
0.11 |
chr1_2348493_2348754 | 0.88 |
PEX10 |
peroxisomal biogenesis factor 10 |
3387 |
0.13 |
chr17_76254387_76254694 | 0.88 |
TMEM235 |
transmembrane protein 235 |
26418 |
0.12 |
chr17_29816216_29816490 | 0.88 |
RAB11FIP4 |
RAB11 family interacting protein 4 (class II) |
1227 |
0.38 |
chr5_169065127_169065524 | 0.87 |
DOCK2 |
dedicator of cytokinesis 2 |
1074 |
0.61 |
chr19_41112390_41112541 | 0.87 |
ENSG00000266164 |
. |
490 |
0.73 |
chr16_53487322_53487473 | 0.87 |
RBL2 |
retinoblastoma-like 2 (p130) |
3409 |
0.2 |
chr2_85077826_85078293 | 0.87 |
TRABD2A |
TraB domain containing 2A |
30147 |
0.17 |
chr20_62671461_62671612 | 0.87 |
ZNF512B |
zinc finger protein 512B |
1598 |
0.21 |
chr17_73329877_73330115 | 0.86 |
RP11-16C1.3 |
|
10490 |
0.1 |
chr14_99695972_99696179 | 0.86 |
AL109767.1 |
|
33210 |
0.17 |
chr17_66235194_66235719 | 0.86 |
AMZ2 |
archaelysin family metallopeptidase 2 |
8259 |
0.16 |
chr12_112430741_112430919 | 0.86 |
TMEM116 |
transmembrane protein 116 |
12959 |
0.16 |
chr11_72744444_72744595 | 0.86 |
FCHSD2 |
FCH and double SH3 domains 2 |
44462 |
0.16 |
chr22_18262424_18262600 | 0.86 |
BID |
BH3 interacting domain death agonist |
5081 |
0.2 |
chr14_90189401_90189552 | 0.86 |
ENSG00000200312 |
. |
10621 |
0.23 |
chr21_45502434_45502585 | 0.86 |
PWP2 |
PWP2 periodic tryptophan protein homolog (yeast) |
24662 |
0.15 |
chr14_99668205_99668356 | 0.86 |
AL162151.4 |
|
43527 |
0.16 |
chr6_35108474_35108709 | 0.86 |
TCP11 |
t-complex 11, testis-specific |
213 |
0.94 |
chr12_783078_783437 | 0.86 |
NINJ2 |
ninjurin 2 |
10312 |
0.19 |
chr6_146188270_146188476 | 0.86 |
SHPRH |
SNF2 histone linker PHD RING helicase, E3 ubiquitin protein ligase |
26117 |
0.2 |
chr16_17508740_17508894 | 0.86 |
XYLT1 |
xylosyltransferase I |
55921 |
0.18 |
chr5_138726582_138726756 | 0.85 |
MZB1 |
marginal zone B and B1 cell-specific protein |
1066 |
0.32 |
chr11_6424260_6424411 | 0.85 |
APBB1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
1559 |
0.3 |
chr1_25946256_25946407 | 0.85 |
MAN1C1 |
mannosidase, alpha, class 1C, member 1 |
1990 |
0.34 |
chr20_2722949_2723333 | 0.85 |
EBF4 |
early B-cell factor 4 |
36254 |
0.09 |
chr19_2562661_2562892 | 0.85 |
CTC-265F19.2 |
|
49084 |
0.09 |
chr11_118811573_118811791 | 0.85 |
ENSG00000239726 |
. |
9762 |
0.07 |
chr10_99530678_99530882 | 0.85 |
SFRP5 |
secreted frizzled-related protein 5 |
929 |
0.55 |
chr5_150524293_150524510 | 0.85 |
ANXA6 |
annexin A6 |
3185 |
0.27 |
chr2_204596528_204596679 | 0.85 |
CD28 |
CD28 molecule |
25187 |
0.19 |
chr18_77282001_77282189 | 0.85 |
AC018445.1 |
Uncharacterized protein |
6038 |
0.3 |
chr19_50835094_50835245 | 0.85 |
KCNC3 |
potassium voltage-gated channel, Shaw-related subfamily, member 3 |
1603 |
0.21 |
chr5_139029570_139029927 | 0.85 |
CXXC5 |
CXXC finger protein 5 |
826 |
0.66 |
chr10_7829391_7829578 | 0.85 |
KIN |
KIN, antigenic determinant of recA protein homolog (mouse) |
460 |
0.56 |
chr12_133410838_133411057 | 0.85 |
ENSG00000252079 |
. |
1139 |
0.41 |
chr2_98337218_98337369 | 0.84 |
ZAP70 |
zeta-chain (TCR) associated protein kinase 70kDa |
4040 |
0.21 |
chr1_167453393_167453610 | 0.84 |
RP11-104L21.2 |
|
25603 |
0.17 |
chr8_144256029_144256199 | 0.84 |
LY6H |
lymphocyte antigen 6 complex, locus H |
13986 |
0.15 |
chr10_76652193_76652344 | 0.84 |
KAT6B |
K(lysine) acetyltransferase 6B |
53810 |
0.15 |
chr16_89803348_89803683 | 0.84 |
FANCA |
Fanconi anemia, complementation group A |
2971 |
0.15 |
chr15_91105896_91106326 | 0.84 |
CRTC3 |
CREB regulated transcription coactivator 3 |
30834 |
0.14 |
chr8_11313733_11313920 | 0.84 |
FAM167A |
family with sequence similarity 167, member A |
10450 |
0.15 |
chr10_8100796_8101134 | 0.83 |
GATA3 |
GATA binding protein 3 |
4196 |
0.36 |
chr1_2348333_2348484 | 0.83 |
PEX10 |
peroxisomal biogenesis factor 10 |
3172 |
0.14 |
chr10_6611978_6612306 | 0.83 |
PRKCQ |
protein kinase C, theta |
10059 |
0.31 |
chr14_99718043_99718194 | 0.83 |
AL109767.1 |
|
11167 |
0.22 |
chr9_139635980_139636260 | 0.83 |
LCN10 |
lipocalin 10 |
1235 |
0.22 |
chr3_66353184_66353448 | 0.83 |
ENSG00000206759 |
. |
9672 |
0.23 |
chr5_150598919_150599070 | 0.82 |
CCDC69 |
coiled-coil domain containing 69 |
4712 |
0.21 |
chr13_114910310_114910591 | 0.82 |
RASA3 |
RAS p21 protein activator 3 |
12364 |
0.21 |
chr1_186276454_186276605 | 0.82 |
ENSG00000202025 |
. |
4531 |
0.21 |
chr11_117817862_117818245 | 0.82 |
TMPRSS13 |
transmembrane protease, serine 13 |
17879 |
0.16 |
chr1_151802545_151802942 | 0.82 |
RORC |
RAR-related orphan receptor C |
1483 |
0.2 |
chr11_60789970_60790185 | 0.82 |
CD6 |
CD6 molecule |
14071 |
0.14 |
chr3_111851090_111851324 | 0.82 |
GCSAM |
germinal center-associated, signaling and motility |
865 |
0.43 |
chr1_117306941_117307092 | 0.82 |
CD2 |
CD2 molecule |
9927 |
0.22 |
chr11_60887053_60887204 | 0.82 |
CD5 |
CD5 molecule |
17147 |
0.16 |
chr12_56733182_56733440 | 0.82 |
IL23A |
interleukin 23, alpha subunit p19 |
648 |
0.46 |
chr14_21250121_21250386 | 0.81 |
RNASE6 |
ribonuclease, RNase A family, k6 |
1043 |
0.34 |
chr12_113525124_113525488 | 0.81 |
DTX1 |
deltex homolog 1 (Drosophila) |
29811 |
0.12 |
chr1_151789622_151789938 | 0.81 |
RORC |
RAR-related orphan receptor C |
8787 |
0.07 |
chr2_233185795_233185978 | 0.81 |
DIS3L2 |
DIS3 mitotic control homolog (S. cerevisiae)-like 2 |
12767 |
0.18 |
chr14_70094548_70094699 | 0.81 |
KIAA0247 |
KIAA0247 |
16310 |
0.22 |
chr19_49957597_49957938 | 0.81 |
PIH1D1 |
PIH1 domain containing 1 |
1013 |
0.21 |
chr2_231226533_231226835 | 0.81 |
SP140L |
SP140 nuclear body protein-like |
19899 |
0.21 |
chr20_42657278_42657643 | 0.81 |
ENSG00000241229 |
. |
21572 |
0.2 |
chr9_78642033_78642303 | 0.81 |
PCSK5 |
proprotein convertase subtilisin/kexin type 5 |
68725 |
0.13 |
chr1_167601008_167601233 | 0.81 |
RP3-455J7.4 |
|
1209 |
0.39 |
chr17_40250698_40250849 | 0.81 |
DHX58 |
DEXH (Asp-Glu-X-His) box polypeptide 58 |
13708 |
0.09 |
chr1_25359763_25359963 | 0.81 |
ENSG00000264371 |
. |
9869 |
0.23 |
chr13_41063588_41063739 | 0.81 |
AL133318.1 |
Uncharacterized protein |
47660 |
0.17 |
chr19_39334299_39334454 | 0.81 |
AC008982.2 |
|
1763 |
0.15 |
chrX_49113740_49113909 | 0.80 |
FOXP3 |
forkhead box P3 |
1138 |
0.29 |
chr17_79420586_79420890 | 0.80 |
ENSG00000266189 |
. |
2524 |
0.16 |
chr17_7120339_7120490 | 0.80 |
ACADVL |
acyl-CoA dehydrogenase, very long chain |
30 |
0.55 |
chr2_182061417_182061737 | 0.80 |
ENSG00000266705 |
. |
108802 |
0.07 |
chr2_231524930_231525146 | 0.80 |
CAB39 |
calcium binding protein 39 |
52522 |
0.12 |
chr4_90216316_90216556 | 0.80 |
GPRIN3 |
GPRIN family member 3 |
12725 |
0.29 |
chr1_205243235_205243736 | 0.80 |
TMCC2 |
transmembrane and coiled-coil domain family 2 |
18156 |
0.15 |
chr3_101778332_101778734 | 0.80 |
ZPLD1 |
zona pellucida-like domain containing 1 |
39555 |
0.2 |
chr6_119056613_119056764 | 0.80 |
CEP85L |
centrosomal protein 85kDa-like |
25450 |
0.24 |
chr11_66060029_66060180 | 0.80 |
TMEM151A |
transmembrane protein 151A |
763 |
0.33 |
chr11_5246485_5246763 | 0.80 |
ENSG00000221031 |
. |
755 |
0.38 |
chr7_150757489_150757734 | 0.80 |
SLC4A2 |
solute carrier family 4 (anion exchanger), member 2 |
454 |
0.62 |
chr21_45774588_45774760 | 0.79 |
TRPM2 |
transient receptor potential cation channel, subfamily M, member 2 |
1103 |
0.32 |
chr6_143146309_143146470 | 0.79 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
11795 |
0.28 |
chr1_108330403_108330665 | 0.79 |
ENSG00000265536 |
. |
11656 |
0.26 |
chr1_206911756_206912053 | 0.79 |
ENSG00000199349 |
. |
9533 |
0.16 |
chr7_2549413_2549701 | 0.79 |
LFNG |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
2606 |
0.23 |
chr5_75626248_75626505 | 0.79 |
RP11-466P24.6 |
|
19089 |
0.25 |
chr22_45060349_45060516 | 0.79 |
PRR5 |
proline rich 5 (renal) |
4161 |
0.26 |
chr5_527247_527623 | 0.79 |
RP11-310P5.2 |
|
2615 |
0.18 |
chr16_88537691_88537842 | 0.79 |
ENSG00000263456 |
. |
2440 |
0.26 |
chr17_61784312_61784470 | 0.79 |
STRADA |
STE20-related kinase adaptor alpha |
2576 |
0.22 |
chr17_36716020_36716220 | 0.79 |
SRCIN1 |
SRC kinase signaling inhibitor 1 |
3540 |
0.2 |
chr17_62980724_62981042 | 0.79 |
AMZ2P1 |
archaelysin family metallopeptidase 2 pseudogene 1 |
11248 |
0.15 |
chr1_226132418_226132746 | 0.79 |
LEFTY2 |
left-right determination factor 2 |
3393 |
0.16 |
chr15_75870421_75870709 | 0.78 |
PTPN9 |
protein tyrosine phosphatase, non-receptor type 9 |
1065 |
0.44 |
chrX_128890428_128890790 | 0.78 |
XPNPEP2 |
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound |
17611 |
0.18 |
chr19_10212945_10213233 | 0.78 |
ANGPTL6 |
angiopoietin-like 6 |
246 |
0.79 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.5 | 1.4 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.4 | 0.4 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.4 | 0.4 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.4 | 1.2 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.4 | 1.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.4 | 1.4 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.4 | 1.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 1.7 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.3 | 1.0 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.3 | 1.3 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.3 | 1.0 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.3 | 1.6 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.3 | 1.6 | GO:2001259 | positive regulation of calcium ion transmembrane transporter activity(GO:1901021) positive regulation of cation channel activity(GO:2001259) |
0.3 | 1.3 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.3 | 0.3 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.3 | 0.6 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 1.2 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.3 | 0.6 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.3 | 0.3 | GO:2000649 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.3 | 0.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.3 | 1.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.3 | 0.6 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.3 | 0.8 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.3 | 0.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 0.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 0.8 | GO:0072162 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.3 | 0.5 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.3 | 0.8 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.3 | 0.3 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.3 | 1.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.3 | 0.8 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.3 | 0.8 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 1.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 0.7 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.2 | 0.2 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.2 | 0.2 | GO:0090009 | primitive streak formation(GO:0090009) |
0.2 | 0.5 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.2 | 1.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 0.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 1.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.2 | 0.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 0.4 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.2 | 0.4 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 0.7 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.6 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.2 | 1.1 | GO:0032933 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 0.6 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.2 | 1.5 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.2 | 0.8 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 0.6 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.2 | 0.6 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 0.2 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 0.6 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.2 | 0.2 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.2 | 1.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.8 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.2 | 0.6 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.2 | 0.6 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.2 | 0.8 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.2 | 11.5 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.2 | 0.4 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.2 | 0.8 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.2 | 1.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.6 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.2 | 0.6 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 0.6 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.2 | 1.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.4 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.2 | 1.9 | GO:0044409 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.2 | 0.8 | GO:0060206 | estrous cycle phase(GO:0060206) |
0.2 | 0.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 0.8 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.2 | 0.6 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.2 | 0.2 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.2 | 0.8 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 0.4 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 1.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 0.6 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.2 | 0.5 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.2 | 0.2 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 0.2 | GO:0010907 | positive regulation of glucose metabolic process(GO:0010907) |
0.2 | 0.7 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.4 | GO:0017085 | response to insecticide(GO:0017085) |
0.2 | 0.9 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 0.3 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.2 | 0.7 | GO:0070977 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.2 | 0.2 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.2 | 0.7 | GO:0048305 | immunoglobulin secretion(GO:0048305) regulation of immunoglobulin secretion(GO:0051023) |
0.2 | 0.7 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.2 | 0.5 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.2 | 1.2 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.2 | 0.2 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.2 | 5.0 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.2 | 0.7 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 0.2 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.2 | 1.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 0.2 | GO:0002249 | lymphocyte anergy(GO:0002249) T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 0.2 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.2 | 0.5 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 0.6 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 0.5 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.2 | 0.5 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.2 | 0.8 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.6 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.2 | 0.5 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.2 | 0.5 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.2 | 0.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.2 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.2 | 1.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.3 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.2 | 0.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.2 | 0.6 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.2 | 1.5 | GO:0001706 | endoderm formation(GO:0001706) |
0.2 | 1.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 1.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.9 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 0.6 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 2.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.9 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 1.6 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.1 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.3 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) sodium ion export(GO:0071436) |
0.1 | 1.7 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.3 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.6 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.4 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.3 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.6 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.1 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.4 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.1 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.8 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.1 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.5 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.5 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.1 | 0.3 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.1 | 0.5 | GO:0043369 | alpha-beta T cell lineage commitment(GO:0002363) CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
0.1 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.4 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.1 | 0.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.1 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.1 | 0.1 | GO:0072074 | kidney mesenchyme development(GO:0072074) metanephric mesenchyme development(GO:0072075) |
0.1 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.5 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.5 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.4 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.1 | 0.4 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.8 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.7 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.4 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.1 | 0.6 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.3 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.1 | 0.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.1 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.1 | 0.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.3 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.1 | 0.5 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.9 | GO:0009304 | tRNA transcription(GO:0009304) |
0.1 | 0.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.1 | GO:0060433 | bronchus development(GO:0060433) |
0.1 | 0.4 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.1 | GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition(GO:0051437) |
0.1 | 0.4 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.7 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.1 | 2.1 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.1 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.1 | 0.2 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 0.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.4 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.1 | 0.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.4 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.1 | GO:1901072 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 0.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.4 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 1.7 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.4 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.4 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.2 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 0.6 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.1 | 0.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.5 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 0.8 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.9 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.3 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.2 | GO:0003211 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.1 | 0.3 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.1 | 0.3 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 1.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.5 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.6 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.3 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.4 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.2 | GO:0071503 | response to heparin(GO:0071503) |
0.1 | 0.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 1.1 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.7 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 1.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.6 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.1 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.1 | 0.4 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.1 | GO:0014044 | Schwann cell development(GO:0014044) |
0.1 | 0.9 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 0.9 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.3 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 0.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.7 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.5 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.3 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.5 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 1.1 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.5 | GO:0033233 | regulation of protein sumoylation(GO:0033233) positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.3 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.6 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 1.7 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.4 | GO:0021681 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.6 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.3 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.1 | 0.4 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.2 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.1 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.4 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.1 | 0.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.4 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 2.6 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.3 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.4 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.2 | GO:0046931 | pore complex assembly(GO:0046931) |
0.1 | 0.4 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.1 | GO:0072217 | negative regulation of metanephros development(GO:0072217) |
0.1 | 0.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.1 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.1 | 0.2 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.3 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
0.1 | 0.3 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 1.4 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.4 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.5 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.1 | GO:0043137 | lagging strand elongation(GO:0006273) DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 4.3 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.1 | 0.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 0.4 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.4 | GO:0002097 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.1 | 0.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.4 | GO:0042635 | positive regulation of hair cycle(GO:0042635) regulation of hair follicle development(GO:0051797) positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.2 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 0.5 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.6 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.3 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 0.9 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 1.4 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.4 | GO:0050671 | positive regulation of lymphocyte proliferation(GO:0050671) |
0.1 | 0.3 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.1 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.1 | 0.5 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.1 | 2.2 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.9 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.5 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.1 | 0.3 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 0.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.2 | GO:0052509 | modulation by symbiont of host defense response(GO:0052031) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) |
0.1 | 0.3 | GO:0072431 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) positive regulation of cell cycle arrest(GO:0071158) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 0.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.3 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.4 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.1 | 0.3 | GO:0008615 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.1 | 0.3 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.9 | GO:0030593 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.1 | 0.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.7 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.3 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.1 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.1 | 0.5 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.2 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 0.2 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.1 | 0.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.5 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.3 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 1.4 | GO:0044728 | DNA methylation or demethylation(GO:0044728) |
0.1 | 0.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 0.3 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.1 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.1 | 0.1 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.2 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.2 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.3 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.2 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.4 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 0.3 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.7 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.2 | GO:0000478 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) cleavage involved in rRNA processing(GO:0000469) endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 1.0 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.1 | 0.1 | GO:0030098 | lymphocyte differentiation(GO:0030098) |
0.1 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 0.4 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.3 | GO:0043247 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 0.4 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.7 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.1 | GO:0034143 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) regulation of toll-like receptor 4 signaling pathway(GO:0034143) positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.5 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.1 | 4.2 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.1 | 0.2 | GO:1901978 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.1 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.3 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.1 | 1.5 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.5 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.3 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 1.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.1 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.2 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.1 | 0.7 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.1 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.1 | 0.6 | GO:0042596 | fear response(GO:0042596) |
0.1 | 0.2 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.2 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.5 | GO:0002429 | immune response-activating cell surface receptor signaling pathway(GO:0002429) |
0.1 | 0.3 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.1 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.1 | 0.6 | GO:0098657 | neurotransmitter uptake(GO:0001504) import into cell(GO:0098657) |
0.1 | 0.2 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 1.0 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 0.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.9 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.1 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 0.1 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
0.1 | 0.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.4 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.1 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.1 | 0.9 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.1 | GO:0043090 | amino acid import(GO:0043090) |
0.1 | 0.4 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.1 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.2 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.1 | 1.1 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.1 | 2.0 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.1 | 0.3 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.4 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.1 | 1.1 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.1 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.1 | 2.0 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.6 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.2 | GO:0032733 | regulation of interleukin-10 production(GO:0032653) positive regulation of interleukin-10 production(GO:0032733) |
0.1 | 1.6 | GO:1901799 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.1 | 0.2 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.9 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.1 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 2.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.1 | GO:0090559 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.1 | 0.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.2 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
0.1 | 0.1 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.1 | 1.7 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.1 | 0.1 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.1 | 0.2 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.1 | 0.8 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.4 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.1 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.1 | 0.5 | GO:0060678 | dichotomous subdivision of terminal units involved in ureteric bud branching(GO:0060678) |
0.1 | 0.3 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.5 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.1 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.1 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
0.1 | 0.2 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.1 | GO:0010823 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.1 | 0.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.3 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.1 | 0.1 | GO:0051170 | nuclear import(GO:0051170) |
0.1 | 0.1 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.1 | 0.1 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.1 | GO:0043324 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.1 | 0.6 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 1.2 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.6 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.3 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.1 | 0.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.1 | GO:0031644 | regulation of neurological system process(GO:0031644) |
0.1 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.2 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.5 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.1 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.2 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.2 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 1.2 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.1 | GO:0031057 | negative regulation of histone modification(GO:0031057) |
0.1 | 0.1 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.1 | 0.3 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.1 | 0.2 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.2 | GO:0000090 | mitotic anaphase(GO:0000090) |
0.1 | 0.3 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 0.1 | GO:0010874 | regulation of cholesterol efflux(GO:0010874) |
0.1 | 0.3 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.2 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.1 | 0.7 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.1 | 0.1 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.1 | 0.1 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.1 | 0.2 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.1 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.1 | 0.3 | GO:0035082 | axoneme assembly(GO:0035082) |
0.1 | 0.1 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.1 | 0.2 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.1 | 0.2 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 1.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.7 | GO:0000045 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.1 | 0.1 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.5 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.2 | GO:0075733 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.1 | 0.2 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.1 | 0.6 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.4 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.1 | 1.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.4 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.3 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.3 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.1 | GO:1903301 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.2 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.1 | 0.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.4 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.3 | GO:0042119 | neutrophil activation(GO:0042119) |
0.1 | 0.9 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.1 | 0.2 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.1 | 0.1 | GO:0009820 | alkaloid metabolic process(GO:0009820) |
0.1 | 0.2 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 0.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.3 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.1 | 0.1 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.1 | 0.2 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 0.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.2 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.1 | GO:0044314 | protein K29-linked ubiquitination(GO:0035519) protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.2 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.3 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 0.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.1 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
0.1 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.6 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 0.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.8 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.0 | 0.5 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 0.1 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.4 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.0 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
0.0 | 0.1 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.0 | 0.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.1 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.0 | 0.4 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:0039703 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.1 | GO:1904251 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.2 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.0 | 0.9 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.0 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.0 | 0.0 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.0 | 0.1 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.9 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.8 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.5 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.4 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.4 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.0 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.0 | 0.0 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.0 | 0.2 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.0 | 0.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.0 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 4.5 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.3 | GO:0031623 | receptor internalization(GO:0031623) |
0.0 | 0.0 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.0 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.9 | GO:0034968 | histone lysine methylation(GO:0034968) |
0.0 | 0.2 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.1 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.0 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.0 | 0.0 | GO:0034651 | cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
0.0 | 0.4 | GO:0007612 | learning(GO:0007612) |
0.0 | 0.0 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.0 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.0 | 0.6 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 1.7 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.0 | 0.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.1 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.4 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.0 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.0 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.0 | 0.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.1 | GO:0097502 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.0 | 0.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.0 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.0 | 0.0 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.0 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.0 | 0.1 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 1.6 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.0 | 0.1 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.5 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.1 | GO:1901862 | negative regulation of striated muscle tissue development(GO:0045843) negative regulation of muscle tissue development(GO:1901862) |
0.0 | 0.3 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.0 | 1.3 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.3 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.1 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.0 | 0.3 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.4 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.0 | GO:0001554 | luteolysis(GO:0001554) |
0.0 | 0.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.3 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.2 | GO:1901998 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.0 | 0.5 | GO:1904590 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein localization to nucleus(GO:1900181) negative regulation of protein import(GO:1904590) |
0.0 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.8 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.7 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.0 | 1.3 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.6 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.1 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.0 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.8 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.0 | 0.2 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.9 | GO:0034134 | toll-like receptor 1 signaling pathway(GO:0034130) toll-like receptor 2 signaling pathway(GO:0034134) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.3 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.0 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.9 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 4.5 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 1.6 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.1 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 1.9 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.3 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.1 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.0 | 0.1 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.1 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.1 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.0 | 0.0 | GO:0006475 | internal protein amino acid acetylation(GO:0006475) |
0.0 | 1.1 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 1.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.4 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.0 | 0.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 1.5 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.0 | 0.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.1 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.0 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.0 | 0.2 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.2 | GO:0070193 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.0 | 0.0 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.1 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.0 | 0.9 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 0.2 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.4 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.3 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.0 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.0 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
0.0 | 0.0 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.1 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.0 | 0.0 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.6 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 3.6 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.0 | 0.7 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 0.2 | GO:2001257 | regulation of calcium ion transmembrane transporter activity(GO:1901019) regulation of cation channel activity(GO:2001257) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.3 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.1 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.0 | 0.4 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 0.0 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 2.9 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 2.9 | GO:0006397 | mRNA processing(GO:0006397) |
0.0 | 0.1 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.0 | 0.1 | GO:0042098 | T cell proliferation(GO:0042098) |
0.0 | 0.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.2 | GO:0051053 | negative regulation of DNA metabolic process(GO:0051053) |
0.0 | 0.1 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
0.0 | 0.1 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.0 | 0.6 | GO:0006913 | nucleocytoplasmic transport(GO:0006913) |
0.0 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.1 | GO:0051318 | G1 phase(GO:0051318) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.4 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.0 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.0 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.1 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.1 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.0 | 0.0 | GO:0070293 | renal absorption(GO:0070293) |
0.0 | 0.0 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.0 | 0.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.1 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.0 | 0.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 1.1 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.1 | GO:0006906 | vesicle fusion(GO:0006906) |
0.0 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) positive regulation of cellular pH reduction(GO:0032849) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 1.0 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.0 | 0.1 | GO:1900087 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.1 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 3.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.0 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.0 | 0.3 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.2 | GO:0000718 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.0 | 0.1 | GO:0045010 | actin nucleation(GO:0045010) |
0.0 | 0.0 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.0 | 0.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 1.0 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.0 | GO:1904063 | negative regulation of cation transmembrane transport(GO:1904063) |
0.0 | 0.1 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.0 | 0.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.6 | GO:0015992 | proton transport(GO:0015992) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.3 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.0 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.0 | 0.0 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.0 | 0.1 | GO:0043049 | otic placode formation(GO:0043049) |
0.0 | 0.0 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.0 | 0.0 | GO:0003341 | cilium movement(GO:0003341) cilium-dependent cell motility(GO:0060285) |
0.0 | 0.1 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.0 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.0 | GO:0040029 | regulation of gene expression, epigenetic(GO:0040029) |
0.0 | 0.1 | GO:0048675 | axon extension(GO:0048675) neuron projection extension(GO:1990138) |
0.0 | 0.0 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.0 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.3 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.0 | 0.0 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.0 | 0.1 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.2 | GO:0042044 | fluid transport(GO:0042044) |
0.0 | 0.0 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.0 | 0.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:0032891 | negative regulation of organic acid transport(GO:0032891) |
0.0 | 0.0 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.0 | 0.0 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.1 | GO:0006309 | DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.3 | GO:0044843 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.0 | 0.2 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 0.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.0 | GO:0070198 | protein localization to chromosome, telomeric region(GO:0070198) |
0.0 | 0.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.0 | GO:1903020 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.0 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.0 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.0 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.0 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.0 | 0.0 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.8 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.0 | 0.0 | GO:0070265 | necrotic cell death(GO:0070265) |
0.0 | 0.1 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.3 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.0 | 0.0 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.0 | GO:1902806 | regulation of cell cycle G1/S phase transition(GO:1902806) regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.0 | 0.2 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 0.2 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.1 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.0 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.1 | GO:0035967 | cellular response to topologically incorrect protein(GO:0035967) |
0.0 | 0.0 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.0 | 0.1 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.1 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.0 | 0.1 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.0 | 0.4 | GO:0042384 | cilium assembly(GO:0042384) |
0.0 | 4.9 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.0 | 0.0 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.0 | 0.1 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 0.0 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 1.2 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.3 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.0 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.5 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.0 | 0.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.3 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.0 | 0.9 | GO:0072503 | cellular calcium ion homeostasis(GO:0006874) cellular divalent inorganic cation homeostasis(GO:0072503) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.1 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.0 | 0.1 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.0 | 0.0 | GO:0034764 | positive regulation of transmembrane transport(GO:0034764) positive regulation of ion transmembrane transport(GO:0034767) |
0.0 | 0.0 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.0 | 0.0 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.0 | 0.0 | GO:0048588 | developmental cell growth(GO:0048588) |
0.0 | 0.0 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.1 | GO:0051899 | membrane depolarization(GO:0051899) |
0.0 | 0.0 | GO:0043271 | negative regulation of ion transport(GO:0043271) |
0.0 | 0.7 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.0 | GO:0007440 | foregut morphogenesis(GO:0007440) |
0.0 | 0.0 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
0.0 | 0.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.0 | GO:2000193 | regulation of icosanoid secretion(GO:0032303) positive regulation of icosanoid secretion(GO:0032305) regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) prostaglandin secretion(GO:0032310) positive regulation of fatty acid transport(GO:2000193) |
0.0 | 0.0 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.0 | 0.0 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
0.0 | 0.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.0 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.0 | 0.2 | GO:0042110 | T cell activation(GO:0042110) leukocyte aggregation(GO:0070486) T cell aggregation(GO:0070489) lymphocyte aggregation(GO:0071593) |
0.0 | 0.2 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.0 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.0 | 0.0 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.0 | 0.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.0 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) positive regulation of neuron death(GO:1901216) |
0.0 | 0.9 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.0 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.0 | 0.2 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.0 | 0.0 | GO:0048284 | organelle fusion(GO:0048284) |
0.0 | 0.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.1 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.0 | GO:1903115 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.0 | 0.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.0 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.0 | 0.0 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.2 | GO:0051403 | stress-activated MAPK cascade(GO:0051403) |
0.0 | 0.1 | GO:0042438 | melanin biosynthetic process(GO:0042438) secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.0 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.0 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.0 | 0.0 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.0 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.0 | 0.0 | GO:0030004 | cellular monovalent inorganic cation homeostasis(GO:0030004) |
0.0 | 1.5 | GO:0006325 | chromatin organization(GO:0006325) |
0.0 | 0.0 | GO:0010458 | exit from mitosis(GO:0010458) |
0.0 | 0.1 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.1 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.0 | GO:0043441 | acetoacetic acid metabolic process(GO:0043438) acetoacetic acid biosynthetic process(GO:0043441) |
0.0 | 0.0 | GO:1903054 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.0 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.0 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.0 | 0.3 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.0 | 3.0 | GO:0006955 | immune response(GO:0006955) |
0.0 | 4.6 | GO:0015031 | protein transport(GO:0015031) |
0.0 | 0.2 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.1 | GO:2000181 | negative regulation of angiogenesis(GO:0016525) negative regulation of vasculature development(GO:1901343) negative regulation of blood vessel morphogenesis(GO:2000181) |
0.0 | 0.4 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.0 | GO:0007033 | vacuole organization(GO:0007033) |
0.0 | 0.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.0 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.3 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.0 | 0.1 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.0 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.1 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.5 | 0.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 1.6 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 1.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.3 | 1.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 0.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 1.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.3 | 1.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 0.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 1.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 0.6 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 0.8 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 1.4 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.2 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.4 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.2 | 2.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 0.5 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.2 | 1.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 1.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 1.0 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 0.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 0.7 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 0.5 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.2 | 1.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 1.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.5 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.2 | 1.5 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.9 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.8 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 1.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 1.2 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.1 | 0.4 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.9 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.6 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.5 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.1 | 1.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 3.4 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.9 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.4 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.1 | 1.0 | GO:0030313 | cell envelope(GO:0030313) |
0.1 | 0.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.6 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 1.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 8.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 1.6 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 0.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.4 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.4 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.6 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.5 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.1 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.1 | 0.1 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.1 | 0.9 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 1.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.5 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 1.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 1.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 1.6 | GO:0032153 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
0.1 | 0.4 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.2 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.1 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 1.0 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.2 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.1 | 1.4 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.6 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 1.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 1.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 1.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.1 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 0.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.3 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.3 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 3.9 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.8 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 1.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.8 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.5 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 3.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.4 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.6 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.1 | 0.1 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.1 | 2.0 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 0.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 6.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.4 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.1 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 1.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.4 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.0 | 0.0 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.3 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.5 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 1.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.5 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 1.5 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.3 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.0 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 2.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 3.5 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.1 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.6 | GO:0042611 | MHC protein complex(GO:0042611) |
0.0 | 0.5 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.0 | 0.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.2 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.0 | 4.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 4.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 1.3 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.0 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.2 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.1 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.1 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.9 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 1.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 1.1 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.0 | 1.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.7 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 1.5 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 3.2 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 1.4 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 3.4 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.3 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 0.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 1.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 2.3 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.1 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.0 | 0.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 1.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 5.9 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.1 | GO:0070822 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.0 | 0.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.0 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 1.3 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.8 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.0 | 0.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.3 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.0 | 0.2 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 1.7 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.8 | GO:0030496 | midbody(GO:0030496) |
0.0 | 7.2 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.3 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.0 | 0.6 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.9 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.3 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 1.3 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.0 | 1.2 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.1 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.0 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 2.5 | GO:0030424 | axon(GO:0030424) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.4 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.9 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.5 | GO:0030426 | growth cone(GO:0030426) site of polarized growth(GO:0030427) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 1.4 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 0.1 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 1.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 107.5 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 9.7 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 1.0 | GO:0005792 | obsolete microsome(GO:0005792) |
0.0 | 0.1 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.1 | GO:0070069 | cytochrome complex(GO:0070069) |
0.0 | 0.5 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.1 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 67.2 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 0.1 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.7 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 9.6 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.0 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.0 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.0 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 1.0 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.6 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.2 | GO:0044450 | microtubule organizing center part(GO:0044450) |
0.0 | 0.0 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.3 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.0 | 6.3 | GO:0005829 | cytosol(GO:0005829) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.3 | 2.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 1.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 1.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.3 | 0.9 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.3 | 0.9 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.3 | 1.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 2.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 1.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.3 | 1.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 0.8 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.3 | 1.9 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.3 | 0.8 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 1.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 1.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 0.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 2.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 0.7 | GO:0001012 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.2 | 0.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 1.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.2 | 0.7 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.2 | 1.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.2 | 0.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.7 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.2 | 0.9 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 1.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 0.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 0.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 0.7 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 0.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 1.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 0.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 0.8 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 1.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 1.0 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 0.6 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 0.6 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.2 | 1.2 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 2.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.9 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 0.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 1.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 0.5 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.2 | 0.4 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.2 | 0.5 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 0.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 1.4 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.5 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 0.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 0.9 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 0.5 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.2 | 1.0 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 0.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 1.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.6 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.2 | 1.3 | GO:0016595 | glutamate binding(GO:0016595) |
0.2 | 0.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 1.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 0.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.3 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 1.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 1.5 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.4 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 1.0 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.3 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 1.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 1.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 1.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 4.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.9 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 2.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 1.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.8 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.6 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.4 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.1 | 0.6 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 1.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 1.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 1.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.6 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 1.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.8 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.6 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.2 | GO:0016895 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.1 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 1.1 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.3 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.1 | 0.3 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.8 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.6 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 1.6 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.6 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 1.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.9 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 1.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.6 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 1.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.6 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.3 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.5 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 1.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.6 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.1 | 0.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 1.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.5 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 1.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.3 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.1 | 0.3 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.6 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.2 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.3 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.1 | 0.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.9 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 1.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.1 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 2.8 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 0.6 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 0.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 0.4 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 1.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.9 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.8 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.7 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.2 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.1 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.2 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.3 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.4 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.1 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.3 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 2.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 3.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.2 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.4 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.1 | 0.3 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 1.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.3 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 2.2 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.1 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.1 | 3.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 1.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.7 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 0.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.1 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 1.0 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 1.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.3 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 1.6 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.1 | 0.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.3 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 0.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 1.4 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.4 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.2 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 0.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.4 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.8 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.5 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.1 | 0.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.2 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.1 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.9 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 1.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 1.4 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 0.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.4 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.2 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.9 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 1.1 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 1.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 1.0 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.9 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 3.6 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.1 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.8 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.4 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.2 | GO:0004083 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.1 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.4 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.5 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 1.3 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.1 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.3 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 1.3 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.0 | 0.2 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.0 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.0 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.0 | 0.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.6 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.1 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.0 | 1.4 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.3 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.0 | 0.5 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.1 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.0 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 1.0 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.6 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.3 | GO:0061630 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 1.1 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 1.3 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 0.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.0 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.0 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.0 | 0.2 | GO:0004396 | hexokinase activity(GO:0004396) |
0.0 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.5 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.6 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 0.0 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.0 | 0.6 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.3 | GO:0015923 | mannosidase activity(GO:0015923) |
0.0 | 0.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.4 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.0 | 1.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.2 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.6 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.2 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.0 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.4 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.2 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.0 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 0.7 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 1.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.9 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 1.3 | GO:0050136 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 3.4 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.0 | 0.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.1 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 3.4 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 1.4 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 6.3 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.8 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 1.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 1.0 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.4 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 1.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 1.1 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.6 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 0.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.6 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.6 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.1 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 1.8 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 1.4 | GO:0008134 | transcription factor binding(GO:0008134) |
0.0 | 13.7 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.2 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.0 | 0.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 50.8 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.2 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.6 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.2 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.2 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.9 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.3 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 2.3 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 0.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.0 | 0.1 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.0 | 1.1 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.1 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 5.8 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 1.4 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.4 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.0 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.2 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.2 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.0 | 0.5 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.8 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.4 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.1 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 5.5 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.0 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 0.0 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.1 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.0 | 0.0 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.1 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.0 | 2.0 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.3 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.0 | 0.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.0 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.0 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.0 | 0.1 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.0 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.1 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.3 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 1.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 2.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.0 | 0.6 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 1.6 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.0 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.1 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.0 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.0 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.4 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) |
0.0 | 0.1 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 19.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 4.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 0.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 1.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 4.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 6.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 2.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 4.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 3.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 2.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 2.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 3.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 2.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 2.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 4.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 1.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 2.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 1.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 2.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 1.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 1.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 1.8 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 1.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 2.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 1.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 1.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.9 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 1.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.9 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.4 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.5 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 1.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 2.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.2 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.4 | 1.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 8.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.3 | 2.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 0.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 5.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 4.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 0.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 0.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 0.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 2.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 0.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 0.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 2.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 0.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 2.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 1.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.9 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 0.7 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 2.0 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 0.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 2.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 2.9 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 0.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 4.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.8 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 2.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 4.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 4.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 1.8 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.2 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.1 | 1.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 3.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.4 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 1.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 0.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.1 | 0.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 3.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 0.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.1 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 1.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 2.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 0.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 0.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.8 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 2.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 1.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 3.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 0.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 2.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 1.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 2.1 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.1 | 0.2 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.5 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 4.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 4.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 3.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.7 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 1.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 1.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 1.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 2.3 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.0 | 0.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 3.0 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.0 | 0.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 2.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 3.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.1 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.0 | 0.2 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.4 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.7 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 1.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.1 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.3 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.1 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 9.0 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.7 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.8 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 1.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 2.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 2.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 1.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.3 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.0 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.3 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.2 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.0 | 0.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.1 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.0 | 0.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.1 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 0.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |